» Articles » PMID: 36761468

Development and Optimization of Nanoparticles Loaded with Erucin, a Dietary Isothiocyanate Isolated from Antioxidant and Antiproliferative Activities in Ehrlich-ascites Carcinoma Cell Line

Overview
Journal Front Pharmacol
Date 2023 Feb 10
PMID 36761468
Authors
Affiliations
Soon will be listed here.
Abstract

The study on Erucin (ER) has gained interest of nutraceutical and pharmaceutical industries because of its anti-cancer properties. Erucin is an isothiocyanate obtained from the seeds of which possess certain drawbacks such as poor aqueous solubility and bioavailability. Therefore, the present study aimed at developing ER-cubosomes (CUB) by solvent evaporation technique followed by applying Central Composite Design to optimize ER loaded cubosomes. For this purpose, independent variables selected were Monoolein (MO) as lipid and Pluronic-84 (P-84) as a stabilizer whereas dependent variables were particle size, percentage of ER loading and percentage of its entrapment efficiency. The cubosomal nanocarriers exhibited particle size in the range of 26 nm, entrapment efficiency of 99.12 ± 0.04% and drug loading of 3.96 ± 0.0001%. Furthermore, to investigate the antioxidant potential, we checked the effect of ER and ER-CUB by DNA nicking assay, DDPH assay and Phosphomolybdate assay, and results showed significant improvement in antioxidant potential for ER-CUB than ER. Similarly, ER-CUB showed enhanced anticancer activity with a marked reduction in IC50 value than ER in MTT assay. These results suggested that ER-CUB produced notable escalation in antioxidant potential and enhanced anticancer activity than ER.

Citing Articles

Innovative nanocarrier systems for enhanced delivery of phyto-active compounds in cancer therapy.

Dwivedi K, Sahoo A, Almalki W, Salman Almujri S, Aodah A, Alruwaili N Nanomedicine (Lond). 2024; 20(1):91-116.

PMID: 39703154 PMC: 11703466. DOI: 10.1080/17435889.2024.2440301.


The Potential of Glucosinolates and Their Hydrolysis Products as Inhibitors of Cytokine Storms.

Ochar K, Iwar K, Nair V, Chung Y, Ha B, Kim S Molecules. 2024; 29(20).

PMID: 39459194 PMC: 11510469. DOI: 10.3390/molecules29204826.


Unlocking the Anticancer Potential of Frankincense Essential Oils (FEOs) Through Nanotechnology: A Review.

Al-Balushi R, Haque A, Saeed M, Al-Harthy T, Al-Hinaai M, Al-Hashmi S Mol Biotechnol. 2023; 66(11):3013-3024.

PMID: 37914864 DOI: 10.1007/s12033-023-00918-5.


The Circular RNA circFOXK2 Enhances the Tumorigenesis of Non-Small Cell Lung Cancer Through the miR-149-3p/IL-6 Axis.

Xiang T, Chen L, Wang H, Yu T, Li T, Li J Biochem Genet. 2023; 62(1):95-111.

PMID: 37256441 DOI: 10.1007/s10528-023-10394-w.

References
1.
Nasr M, Almawash S, Al Saqr A, Bazeed A, Saber S, Elagamy H . Bioavailability and Antidiabetic Activity of Gliclazide-Loaded Cubosomal Nanoparticles. Pharmaceuticals (Basel). 2021; 14(8). PMC: 8398842. DOI: 10.3390/ph14080786. View

2.
Kaur P, Singh D, Singh G, Attri S, Singh D, Sharma M . Pharmacokinetics and toxicity profiling of 4-(methylthio)butyl isothiocyanate with special reference to pre-clinical safety assessment studies. Toxicon. 2022; 212:19-33. DOI: 10.1016/j.toxicon.2022.03.016. View

3.
Awadelkareem A, Al-Shammari E, Elkhalifa A, Adnan M, Siddiqui A, Patel M . Biosynthesized Silver Nanoparticles from Miller Leaf Extract Exhibits Antibacterial, Antioxidant, Anti-Quorum-Sensing, Antibiofilm, and Anti-Metastatic Activities. Antibiotics (Basel). 2022; 11(7). PMC: 9311509. DOI: 10.3390/antibiotics11070853. View

4.
Liu Z, Ni H, Yu L, Xu S, Bo R, Qiu T . Adjuvant activities of CTAB-modified Polygonatum sibiricum polysaccharide cubosomes on immune responses to ovalbumin in mice. Int J Biol Macromol. 2020; 148:793-801. DOI: 10.1016/j.ijbiomac.2020.01.174. View

5.
Zhao H, Lin J, Grossman H, Hernandez L, Dinney C, Wu X . Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. Int J Cancer. 2007; 120(10):2208-13. DOI: 10.1002/ijc.22549. View